How has been the historical performance of Gayatri BioOrga.?

Answer:The historical performance of Gayatri BioOrga shows a challenging trend with limited revenue generation and consistent losses over the years.

Breakdown:
Gayatri BioOrga's net sales remained stagnant at zero for the years ending March 2024 and March 2025, with a slight revenue of 1.67 crore recorded in March 2023. The total operating income followed a similar pattern, reflecting the same figures. The company incurred raw material costs of 1.59 crore in March 2023, but this was not matched by any sales in subsequent years. Employee costs peaked at 0.29 crore in March 2022 but have since decreased to 0.09 crore by March 2025. The total expenditure excluding depreciation was highest in March 2023 at 2.44 crore, leading to an operating profit (PBDIT) of -0.77 crore for that year, which further deteriorated to -0.45 crore by March 2025. Interest expenses increased from 0.03 crore in March 2023 to 0.28 crore in March 2025, contributing to a profit before tax of -0.73 crore in the latest year. The company has consistently reported negative profit after tax, with the most significant loss of -1.01 crore in March 2023. Shareholder's funds have been negative, amounting to -35.89 crore in March 2025, while total liabilities were recorded at 1.66 crore. The cash flow statements indicate no cash inflows or outflows for the last three years, reflecting a lack of operational activity. Overall, Gayatri BioOrga's financial performance has been marked by persistent losses, minimal revenue, and a deteriorating financial position.